Adial Pharmaceuticals, Inc. (ADIL) vs Kiora Pharmaceuticals, Inc. (KPRX)

Adial Pharmaceuticals, Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Adial Pharmaceuticals, Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($11.8M and $11.3M). Across the 10 metrics below, Kiora Pharmaceuticals, Inc. leads on 6 and Adial Pharmaceuticals, Inc. on 4.

Valuation

Metric ADIL KPRX Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.87 11.47
P/B n/m 0.96 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.16 0.05 0.74
EV/Sales n/m (0.03) 10.73
Earnings yield (379.24%) (94.06%) (28.84%)
Free cash flow yield (56.08%) (53.02%) (23.03%)

Profitability

Metric ADIL KPRX Biotechnology median
Gross margin 0.00% 85.06% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 352.60% (56.36%) (57.72%)
Return on assets (322.10%) (39.43%) (49.22%)
Return on invested capital 0.00% (44,053.91%) 0.00%

Growth

Metric ADIL KPRX Biotechnology median
Revenue growth (TTM) — 983.73% 5.64%
EPS growth (last fiscal year) 82.46% (403.45%) —
Revenue growth, 5-year CAGR — 88.72% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADIL KPRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.63 8.97 4.73
Net debt to EBITDA 0.75 1.33 0.96

Dividend

Metric ADIL KPRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ADIL KPRX Biotechnology median
Market cap 11.33m 11.81m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack